tiprankstipranks
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
India Market
SUNPHARMA
Sun Pharmaceutical Industries Limited
RESEARCH TOOLSreports
Want to see IN:SUNPHARMA full AI Analyst Report?

Sun Pharmaceutical Industries Limited (SUNPHARMA) Ratios

15 Followers

Sun Pharmaceutical Industries Limited Ratios

IN:SUNPHARMA's free cash flow for Q2 2026 was ₹0.55. For the 2026 fiscal year, IN:SUNPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.29. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 2.57 2.89 2.56 2.00 2.04
Quick Ratio
 2.12 2.33 1.95 1.47 1.50
Cash Ratio
 0.52 0.62 0.55 0.23 0.26
Solvency Ratio
 0.53 0.68 0.65 0.50 0.28
Operating Cash Flow Ratio
 0.20 0.77 0.71 0.25 0.52
Short-Term Operating Cash Flow Coverage
 0.99 7.54 4.27 0.80 12.82
Net Current Asset Value
₹ 345.57B₹ 330.10B₹ 250.76B₹ 184.34B₹ 162.81B
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.03 0.04 0.09 0.02
Debt-to-Equity Ratio
 0.07 0.03 0.05 0.12 0.03
Debt-to-Capital Ratio
 0.06 0.03 0.05 0.11 0.03
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.00 <0.01
Financial Leverage Ratio
 1.33 1.28 1.34 1.44 1.45
Debt Service Coverage Ratio
 2.64 6.00 3.71 1.70 11.71
Interest Coverage Ratio
 56.11 169.28 102.42 148.94 245.23
Debt to Market Cap
 0.01 <0.01 <0.01 0.03 <0.01
Interest Debt Per Share
 22.99 10.54 14.64 29.33 5.69
Net Debt to EBITDA
 -0.40 -0.60 -0.47 0.19 -0.32
Profitability Margins
Gross Profit Margin
59.84%78.02%76.41%74.21%71.86%
EBIT Margin
25.83%23.97%21.69%21.20%21.10%
EBITDA Margin
30.68%28.47%26.55%26.55%26.27%
Operating Profit Margin
29.85%52.90%50.36%49.91%47.32%
Pretax Profit Margin
26.01%26.13%22.78%21.33%11.55%
Net Profit Margin
19.21%20.79%19.75%19.31%8.47%
Continuous Operations Profit Margin
19.28%20.85%19.82%19.40%8.77%
Net Income Per EBT
73.88%79.56%86.67%90.52%73.30%
EBT Per EBIT
87.13%49.39%45.24%42.73%24.41%
Return on Assets (ROA)
10.53%11.87%11.21%10.49%4.69%
Return on Equity (ROE)
14.96%15.13%15.04%15.13%6.82%
Return on Capital Employed (ROCE)
21.12%37.64%35.67%36.00%34.78%
Return on Invested Capital (ROIC)
14.76%29.25%29.73%29.67%26.00%
Return on Tangible Assets
13.52%14.74%14.04%13.51%5.72%
Earnings Yield
2.60%2.68%2.45%3.59%1.49%
Efficiency Ratios
Receivables Turnover
 3.68 4.03 4.31 3.83 3.49
Payables Turnover
 3.40 1.87 2.02 1.99 2.43
Inventory Turnover
 2.18 1.13 1.11 1.08 1.18
Fixed Asset Turnover
 4.83 4.67 4.29 3.87 3.46
Asset Turnover
 0.55 0.57 0.57 0.54 0.55
Working Capital Turnover Ratio
 3.09 1.73 2.09 2.32 2.41
Cash Conversion Cycle
 159.04 218.74 232.81 251.09 264.31
Days of Sales Outstanding
 99.25 90.57 84.75 95.29 104.57
Days of Inventory Outstanding
 167.08 323.47 328.40 339.02 310.06
Days of Payables Outstanding
 107.29 195.29 180.34 183.22 150.33
Operating Cycle
 266.33 414.04 413.15 434.31 414.63
Cash Flow Ratios
Operating Cash Flow Per Share
 19.93 58.71 50.58 20.67 37.45
Free Cash Flow Per Share
 9.97 49.83 41.40 11.98 31.21
CapEx Per Share
 9.95 8.88 9.18 8.69 6.23
Free Cash Flow to Operating Cash Flow
 0.50 0.85 0.82 0.58 0.83
Dividend Paid and CapEx Coverage Ratio
 1.29 2.45 2.38 1.08 2.46
Capital Expenditure Coverage Ratio
 2.00 6.61 5.51 2.38 6.01
Operating Cash Flow Coverage Ratio
 0.92 5.96 3.71 0.72 6.96
Operating Cash Flow to Sales Ratio
 0.08 0.27 0.25 0.11 0.23
Free Cash Flow Yield
0.57%2.93%2.54%1.22%3.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 35.58 37.24 40.82 27.84 67.06
Price-to-Sales (P/S) Ratio
 6.84 7.74 8.06 5.37 5.68
Price-to-Book (P/B) Ratio
 4.99 5.64 6.14 4.21 4.57
Price-to-Free Cash Flow (P/FCF) Ratio
 162.31 34.08 39.35 82.08 29.30
Price-to-Operating Cash Flow Ratio
 81.22 28.93 32.21 47.56 24.43
Price-to-Earnings Growth (PEG) Ratio
 -7.79 2.61 3.14 0.18 5.27
Price-to-Fair Value
 4.99 5.64 6.14 4.21 4.57
Enterprise Value Multiple
 21.88 26.60 29.89 20.44 21.30
Enterprise Value
 4.12T 3.98T 3.85T 2.38T 2.16T
EV to EBITDA
 23.65 26.60 29.89 20.44 21.30
EV to Sales
 7.26 7.57 7.94 5.43 5.59
EV to Free Cash Flow
 172.28 33.33 38.75 82.87 28.88
EV to Operating Cash Flow
 86.21 28.29 31.72 48.02 24.07
Tangible Book Value Per Share
 229.91 227.50 207.73 172.03 160.41
Shareholders’ Equity Per Share
 324.34 301.32 265.35 233.38 200.10
Tax and Other Ratios
Effective Tax Rate
 0.26 0.20 0.13 0.09 0.24
Revenue Per Share
 236.77 219.38 202.13 182.91 161.11
Net Income Per Share
 45.49 45.60 39.91 35.32 13.64
Tax Burden
 0.74 0.80 0.87 0.91 0.73
Interest Burden
 1.01 1.09 1.05 1.01 0.55
Research & Development to Revenue
 0.06 0.06 0.06 0.05 0.06
SG&A to Revenue
 0.24 0.19 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.38 1.29 1.27 0.53 2.00
Currency in INR